Stocks · News reference
Curis Commences ~$8.5M Offering Of 16.666M Common Shares, Warrants At $0.51 Per Share
Curis, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.
Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Veea jumps 34% after regaining Nasdaq compliance; Freight Technologies leads gainers, while Alignment Healthcare plunges 24% among premarket losers.